Varenicline decreases ethanol intake and increases dopamine release via neuronal nicotinic acetylcholine receptors in the nucleus accumbens

The Concise Guide to PHARMACOLOGY 2013/14: Ligand-Gated Ion Channels

(2013) Stephen P.H. Alexander et al.   BRITISH JOURNAL OF PHARMACOLOGY

A Double-Blind, Placebo-Controlled Trial Assessing the Efficacy of Varenicline Tartrate for Alcohol Dependence

(2013) Raye Z. Litten et al.   Journal of Addiction Medicine

Neuronal Nicotinic Acetylcholine Receptors as Pharmacotherapeutic Targets for the Treatment of Alcohol Use Disorders

(2012) S. Chatterjee et al.   CNS & Neurological Disorders-Drug Targets

Striatal  5 Nicotinic Receptor Subunit Regulates Dopamine Transmission in Dorsal Striatum

(2012) R. Exley et al.   JOURNAL OF NEUROSCIENCE

Striatal Dopamine Release Is Triggered by Synchronized Activity in Cholinergic Interneurons

(2012) Sarah Threlfell et al.   NEURON

Varenicline decreases alcohol consumption in heavy-drinking smokers

(2012) Jennifer M. Mitchell et al.   PSYCHOPHARMACOLOGY

Selective Activation of Cholinergic Interneurons Enhances Accumbal Phasic Dopamine Release: Setting the Tone for Reward Processing

(2012) Roger Cachope et al.   Cell Reports

Ghrelin receptor (GHS-R1A) antagonism suppresses both operant alcohol self-administration and high alcohol consumption in rats

(2011) Sara Landgren et al.   ADDICTION BIOLOGY

Pre-clinical properties of the α4β2 nicotinic acetylcholine receptor partial agonists varenicline, cytisine and dianicline translate to clinical efficacy for nicotine dependence

(2010) H Rollema et al.   BRITISH JOURNAL OF PHARMACOLOGY

Guidelines for reporting experiments involving animals: the ARRIVE guidelines

(2010) JC McGrath et al.   BRITISH JOURNAL OF PHARMACOLOGY

Animal research: Reporting in vivo experiments: The ARRIVE guidelines

(2010) Carol Kilkenny et al.   BRITISH JOURNAL OF PHARMACOLOGY

Activation of  4* nAChRs is Necessary and Sufficient for Varenicline-Induced Reduction of Alcohol Consumption

(2010) L. M. Hendrickson et al.   JOURNAL OF NEUROSCIENCE

Structural differences determine the relative selectivity of nicotinic compounds for native α4β2*-, α6β2*-, α3β4*- and α7-nicotine acetylcholine receptors

(2010) Sharon R. Grady et al.   NEUROPHARMACOLOGY

Partial Agonists of the α3β4* Neuronal Nicotinic Acetylcholine Receptor Reduce Ethanol Consumption and Seeking in Rats

(2010) Susmita Chatterjee et al.   NEUROPSYCHOPHARMACOLOGY

Modulation of ethanol consumption by genetic and pharmacological manipulation of nicotinic acetylcholine receptors in mice

(2010) Helen M. Kamens et al.   PSYCHOPHARMACOLOGY

The Dopamine Response in the Nucleus Accumbens Core-Shell Border Differs From That in the Core and Shell During Operant Ethanol Self-Administration

(2009) Elaina C. Howard et al.   ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH

Varenicline Reduces Alcohol Self-Administration in Heavy-Drinking Smokers

(2009) Sherry A. McKee et al.   BIOLOGICAL PSYCHIATRY

Varenicline: A first-line treatment option for smoking cessation

(2009) Gina Daubney Garrison et al.   CLINICAL THERAPEUTICS

Rodent Habenulo-Interpeduncular Pathway Expresses a Large Variety of Uncommon nAChR Subtypes, But Only the  3 4 and  3 3 4 Subtypes Mediate Acetylcholine Release

(2009) S. R. Grady et al.   JOURNAL OF NEUROSCIENCE

The Smoking Cessation Medication Varenicline Attenuates Alcohol and Nicotine Interactions in the Rat Mesolimbic Dopamine System

(2009) M. Ericson et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Controls of Tonic and Phasic Dopamine Transmission in the Dorsal and Ventral Striatum

(2009) L. Zhang et al.   MOLECULAR PHARMACOLOGY

Intermittent Access to 20% Ethanol Induces High Ethanol Consumption in Long-Evans and Wistar Rats

(2008) Jeffrey A. Simms et al.   ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH